APA (7th ed.) Citation

Klinke, O., Mizani, T., Baldwin, G., Bancel, B., Devouassoux-Shisheboran, M., Scoazec, J., . . . Delecluse, H. (2015). KIT mutation and loss of 14q may be sufficient for the development of clinically symptomatic very low-risk GIST. PLOS ONE, 10(6), . https://doi.org/10.1371/journal.pone.0130149

Chicago Style (17th ed.) Citation

Klinke, Olaf, et al. "KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-risk GIST." PLOS ONE 10, no. 6 (2015). https://doi.org/10.1371/journal.pone.0130149.

MLA (9th ed.) Citation

Klinke, Olaf, et al. "KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-risk GIST." PLOS ONE, vol. 10, no. 6, 2015, https://doi.org/10.1371/journal.pone.0130149.